This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pouzet, M. T. Articles by Travis, E. L. Search for Related Content PubMed PubMed Citation Articles by Pouzet, M. T. Articles by Travis, E. L.

No Change in Repair Capacity of Mouse Lung Irradiated Three Months after a Single Dose of Cyclophosphamide¹

Department of Experimental Radiotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The repair capacity of mouse lung was determined at 3 months after a single i.p. injection of cyclophosphamide (Cy) at a maximally tolerated dose of 275 mg/kg. Mice were irradiated to the whole thorax only with 1, 2, 9, or 15 fractions of X-rays using doses/fraction ranging from 1.2 to 11 Gy. Breathing rate (breaths per minute), histology and pulmonary mortality were used to assess lung damage. Raw breathing rate data were cnverted to quantal response data by scoring the number of mice in each dose group in each fractionation schedule with a breathing rate 1.3 times the breathing rate of control mice. Dose-response curves of mortality and the converted breathing rate data were constructed at 15 weeks after irradiation (approximately 28 weeks after drug treatment) fitted by logit analysis and 50% effective doses with 95% confidence limits obtained. Values of /ß were obtained by using the direct analysis method of H. D. Thames et al. (Int. J. Radiat. Biol., 49: 999–1009, 1986).

The /ß for mice given Cy 3 months before radiation was 3.69 Gy (95% confidence limits, 2.83, 4.69 Gy) and 3.06 Gy (95% confidence limits, 2.31, 3.99 Gy) for the lethality data and breathing rate data, respectively. These /ß values are in good agreement with the previously published ranges of /ß of 3 to 4 Gy for mouse lung not given Cy previously. Because the repair capacity of the target cells of a tissue govern the fractionation response and choice of fractionation regimen in clinical radiotherapy, these data indicate that the fractionation regimen used can remain the same as that used in non-drug-treated lungs when the lung is irradiated 3 months after exposure to Cy.

¹ Supported by National Cancer Institute Grants CA-38106 and CA-06294.

² To whom requests for reprints should be addressed, at the University of Texas M. D. Anderson Cancer Center, Houston, TX 77030.

Received 5/13/91. Accepted 12/13/91.